European Union - English - EMA (European Medicines Agency)

unigene uk ltd. - recombinant salmon calcitonin - hypercalcemia; osteitis deformans; bone resorption - calcium homeostasis - calcitonin is indicated for:prevention of acute bone loss due to sudden immobilisation such as in patients with recentosteoporotic fracturespaget's diseasehypercalcaemia of malignancy

European Union - English - EMA (European Medicines Agency)

pfizer limited - recombinant inactivated avian influenza virus - immunologicals - chicken; ducks - for active immunisation of chickens and ducks against avian influenza virus type a, subtype h5.chickens:reduction of mortality and virus excretion after challenge.onset of immunity: 3 weeks after the second injection.duration of immunity in chickens has not been established yet.ducks: reduction of clinical signs and virus excretion after challenge.onset of immunity: 3 weeks after the second injection.duration of immunity in ducks : 14 weeks after the second injection.

Israel - English - Ministry of Health

j-c health care ltd - recombinant human erythropoietin - solution for injection - recombinant human erythropoietin 3000 iu / 0.3 ml - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicated for patients at high risk for periopertive transfusions with significant, anticipated blood loss. eprex is not indicated for anemic patients who are willing to donate autologous blood. the safety of the perioperative use of eprex has been studied only in patients who are receiving anticoagulant prophylaxis. eprex is indicated before surgerios known be associated with excessive blood loss (at least 2 units ).

Israel - English - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 1000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

Israel - English - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 2000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

Israel - English - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 250 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

Israel - English - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 500 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

Kenya - English - Pharmacy and Poisons Board

transagro enterprises limited p.o. box 15926-00100 nairobi - recombinant human epidermal growth factor (rhegf). - injection - recombinant human epidermal growth factor 0.075 mg - other cicatrizants

Kenya - English - Pharmacy and Poisons Board

intas pharmaceuticals ltd chinubhai centre off. nehru bridge ashram road - recombinant human erythropoietin - injection - recombinant human erythropoietin 2000 iu - other antianemic preparations

Kenya - English - Pharmacy and Poisons Board

intas pharmaceuticals ltd chinubhai centre off. nehru bridge ashram road - recombinant human erythropoietin - injection - recombinant human erythropoietin 4000 iu - other antianemic preparations